Blue Crest Capital Management LTD Abb Vie Inc. Put Options Transaction History

Blue Crest Capital Management LTD

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 15, 2024	SELL	$159.82 - $182.1 $6.28 Million - $7.16 Million	-39,300 Reduced 59.55%	26,700 $4.86 Million
Q4 2023 Feb 14, 2024	BUY	$137.6 - $154.97 $3.67 Million - $4.14 Million	26,700 Added 67.94%	66,000 $10.2 Million
Q3 2023 Nov 14, 2023	BUY	$133.59 - $154.65 $5.25 Million - $6.08 Million	39,300 New	39,300 $5.86 Million
Q4 2018 Feb 14, 2019	SELL	$77.85 - $96.01 $1.95 Million - $2.4 Million	-25,000 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$88.91 - $98.84 $2.22 Million - $2.47 Million	25,000 New	25,000 $2.37 Million

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Blue Crest Capital Management LTD, based on Form 13F filings with the SEC.

Stay updated on Blue Crest Capital Management LTD with notifications on news.